Stock listing

Relmada Therapeutics, Inc.

Selected listing: 4E2 · FWB · EUR · DE

Relmada Therapeutics, Inc. (Frankfurt:4E2), Health Technology. Latest release Sep 1, 2026: Relmada Therapeutics to Participate at the Wells Fargo 21st Annual…

4E2:FWBEURDEUpdated October 2, 2026

Ticker: Frankfurt:4E2
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Frankfurt
Currency: EUR

Latest news from Relmada Therapeutics, Inc.

Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference

September 1, 2026

Relmada Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

August 6, 2026

Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer

July 28, 2026

Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026

July 16, 2026

Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes

June 29, 2026

All Relmada Therapeutics, Inc. news →

Events

Replays

Relmada Therapeutics, Inc. (RLMD) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 04:30 PM ET
Watch
Relmada Therapeutics, Inc. (RLMD) Q1 2026 Earnings Call
Tue, May 12, 2026 · 04:30 PM ET
Watch
Relmada Therapeutics, Inc. (RLMD) Q4 2025 Earnings Call
Thu, Mar 19, 2026 · 04:30 PM ET
Watch

Research Relmada Therapeutics, Inc.

Relmada Therapeutics, Inc. company profile

View the public company page for Relmada Therapeutics, Inc. on 6ix.

Relmada Therapeutics, Inc. news

Read company news and market updates connected to Relmada Therapeutics, Inc..

Relmada Therapeutics, Inc. investor events

Find investor webinars, events, and replay context for Relmada Therapeutics, Inc..